E-LIB Suche - Ergebnisse für: Spigel, David

1

Tislelizumab plus chemotherapy versus placebo plus chemothe..:

Qiu, Miao-Zhen ; Oh, Do-Youn ; Kato, Ken...
BMJ. , 2024

Link: https://doi.org/10.1136/..

2

A Phase Ib Study Assessing the Safety, Tolerability, and Ef..:

Bauer, Todd M. ; Moore, Kathleen N. ; Rader, Janet S....
Targeted Oncology. 18 (2023) 4 - p. 517-530 , 2023

Link: https://doi.org/10.1007/..

3

Durable responders in advanced NSCLC with elevated TMB and ..:

Huang, Richard S P ; Carbone, David P ; Li, Gerald...
Journal for ImmunoTherapy of Cancer. 11 (2023) 1 - p. e005801 , 2023

Link: https://doi.org/10.1136/..

4

In situ tumour arrays reveal early environmental control of..:

Ortiz-Muñoz, Guadalupe ; Brown, Markus ; Carbone, Catherine B....
Nature. 618 (2023) 7966 - p. 827-833 , 2023

Link: https://doi.org/10.1038/..

5

54. Concordance of blood and tissue TMB from real-world NGS..:

Sturgill, Emma ; Misch, Amanda ; Jones, Carissa...
Cancer Genetics. 260-261 (2022) - p. 18 , 2022

Link: https://doi.org/10.1016/..

6

A real-world retrospective study of the use of Ki-67 testin..:

Brown, Jacqueline ; Scardo, Savannah ; Method, Michael...
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

7

Long-Term Avelumab in Advanced Non-Small-Cell Lung Cancer: ..:

Hrinczenko, Borys ; Iannotti, Nicholas ; Goel, Sanjay...
Future Oncology. 18 (2022) 11 - p. 1333-1342 , 2022

Link: https://doi.org/10.2217/..

8

Patient-Reported Outcomes with Durvalumab by PD-L1 Expressi..:

Garassino, Marina C ; Paz-Ares, Luis ; Hui, Rina...
Future Oncology. 17 (2021) 10 - p. 1165-1184 , 2021

Link: https://doi.org/10.2217/..

9

Impact of subsequent immune checkpoint inhibitor treatment ..:

Park, Keunchil ; Özgüroğlu, Mustafa ; Vansteenkiste, Johan...
Lung Cancer. 154 (2021) - p. 92-98 , 2021

Link: https://doi.org/10.1016/..

10

Avelumab Versus Docetaxel in Patients With Platinum-Treated..:

Park, Keunchil ; Özgüroğlu, Mustafa ; Vansteenkiste, Johan...
Journal of Thoracic Oncology. 16 (2021) 8 - p. 1369-1378 , 2021

Link: https://doi.org/10.1016/..

11

nab-Paclitaxel/Carboplatin in Vulnerable Populations With A..:

Langer, Corey J. ; Gajra, Ajeet ; Gridelli, Cesare...
Frontiers in Oncology. 10 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

12

Efficacy and safety of first-line avelumab in patients with..:

Verschraegen, Claire F ; Jerusalem, Guy ; McClay, Edward F...
Journal for ImmunoTherapy of Cancer. 8 (2020) 2 - p. e001064 , 2020

Link: https://doi.org/10.1136/..

13

Safety profile of nivolumab administered as 30-min infusion..:

Waterhouse, David ; Horn, Leora ; Reynolds, Craig...
Cancer Chemotherapy and Pharmacology. 81 (2018) 4 - p. 679-686 , 2018

Link: https://doi.org/10.1007/..

14

Retrospective Assessment of a Serum Proteomic Test in a Pha..:

Buttigliero, Consuelo ; Shepherd, Frances A. ; Barlesi, Fabrice...
The Oncologist. 24 (2018) 6 - p. e251-e259 , 2018

Link: https://doi.org/10.1634/..

15

P3.02c-026 Is Nivolumab Safe and Effective in Elderly and P..:

Spigel, David ; Schwartzberg, Lee ; Waterhouse, David...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1287-S1288 , 2017

Link: https://doi.org/10.1016/..